About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 39 record(s)
Req # A-2024-54596
Submission of the Public Health Agency of Canada (PHAC) to the Patented Medicine Prices Review Board’s November 2023 consultation on the Scoping paper of the Board's Guidelines. Submissions from other stakeholders can be viewed here: https://www.canada.ca/en/patented-medicine-prices-review/services/consultations/scoping-paper-board-guidelines.htmlOrganization: Patented Medicine Prices Review Board Canada
February 2024
Nothing to report this month
Organization: Canadian Museum of Nature
Nothing to report this month
Organization: Financial Consumer Agency of Canada
Nothing to report this month
Organization: Military Grievances External Review Committee
Req # A-2022-00079
The agreement or contract between TC Transcontinental and Canada Post to distribute Publisacs within the City of Montreal itself; the duration of the agreement; the number of dwellings that will be served in the Côte-des-Neiges-Notre-Dame de-Grâce borough; the distribution cost per dwelling in the borough; the distribution frequency per dwelling; expected deployment in the other boroughs (schedule, boroughs and number of dwellings concerned); the total number of dwellings that will be served in the 19 boroughs; the distribution cost per dwelling in the 19 boroughs.Organization: Canada Post
February 2023
Req # A-2022-00083
records of Covid-19 cases, at all Canada Post facilities and/or involving Canada Post employees by location/city and province from April 1, 2022, to September 30, 2022.Organization: Canada Post
February 2023
Req # A-2023-00007
Records and in regarding a deceased woman who worked for Canada Post in Toronto in 1968 – 1969.Organization: Canada Post
February 2023
Req # 23-1007-100
Museum policies concerning receiving donations, funds, sponsorships, support for exhibits etc. from various entities/Communication of discussion within the museum about the involvement of oil and gas companies (e.g., Enbridge, Tundra Oil & Gas, and any others including trade associations etc.) from 2016 to the present.Organization: Canadian Museum of Nature
February 2023
Req # A-2023-02395
Copies of all correspondence and communications between the (then) acting chairperson of the Patented Medicines Prices Review Board Mélanie Bourassa-Forcier and Innovative Medicines Canada (IMC) between October 1, 2022 and December 5, 2022 regarding the PMPRB's new draft guidelines and the consultation process. Please include all responses to Innovative Medicines Canada (IMC)'s communications/correspondence from the (then) acting chairperson of the Patented Medicines Prices Review Board Mélanie Bourassa-Forcier.Organization: Patented Medicine Prices Review Board Canada
February 2023
Req # A-2022-09063
Copies of any emails sent by the Vice-chair regarding any of the following topics: (i) her resignation or intent to resign or the reasons for her resignation. (ii) the draft guidelines. (iii) the consultation process for the draft guidelines. (iv) the impact of the Merck Canada, IMC, and/or Alexion court decisions on the PMPRB, including its draft guidelines. From November 1, 2022 to December 5, 2022.Organization: Patented Medicine Prices Review Board Canada
February 2023